Company logo

Global Precision Medicine Leader

Bayer AG (3-PROD)


Online bewerbenopen_in_new

Global Precision Medicine Leader

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At Bayer you have the opportunity to be part of a culture where we value the passion of our employees to innovate and give them the power to change

Global Precision Medicine Leader


  • Will be Precision Medicine Leader (PML) for development of one or more programs and resume in this role strategic, clinical, scientific, technical and budgetary planning for the assigned projects.
  • Act as an equal member of the GPT, when required. Will provide relevant Oncology expertise to GPT when evaluating and developing precision medicine strategies
  • Acts as thought partner to research leaders, proactively following early projects and taking an active role from pre-IND, assembling resources for subsequent biomarker activities on the project. Will draw on resources from across the organization, to ensure delivery of appropriate biomarker strategy
  • Ensures coordination of all aspects of biomarker delivery in synchronization with the drug R&D process, informed by deep understanding of clinical development in Oncology and state-of-the-art biomarker use in Oncology.
  • Will own, source and develop distinctive biomarker knowledge to support Bayer differentiation strategy, when necessary.
  • Defines, communicates and executes on the biomarker strategy for each development program where he/she is PML; represents biomarker related aspects internally and externally in meetings with authorities and ethics committees, and with external key opinion leaders; builds and maintains network with academic institutions/diagnostic companies in Oncology.
  • Will work closely with clinical leaders to ensure translation strategy has maximum success rate supported by a developable biomarker
  • Leads via internal and external collaborations the development of biomarkers and/or segmentation tools for internal decision making and/or as intended part of the product definition, whether to measure response (to aid dose finding or as surrogate endpoint) or to identify patient segments
  • Ensure regulatory compliance of biomarker activities and drives biomarker qualification processes
  • Independently analyses, interprets and presents results from biomarker analyses and draws scientifically valid conclusions that support and enable decision making


  • Medical doctor (MD) and/or PhD in Pathology, Biochemistry, Molecular Biology, or Genetics
  • Significant and long-term industry experience with a proven track record of clinical development in oncology
  • understanding of pathophysiologies and therapies in oncology.
  • Focus on early stage drug development, including experience with implementing biomarker strategies in phase I, regulatory framework for biosampling, translational medicine in Oncology
  • Outstanding scientific reputation as evidenced by multiple publications in peer reviewed journals and as speaker of conferences;
  • Strong network in the academic and clinical community of Oncology
  • Strong leadership skills, comfortable to marshal resources from different parts of the organization
  • Fluent written and spoken English skills

We are looking forward to receiving your application by 21st April. Thank you!





Reference Code: